Our people are world leading industry experts and healthcare management innovators. Meet our team here.
Professor Nora Colton is the Director of the UCL Global Business School of Health. She is a health and development economist with extensive experience in change management and strategy. Previous to this role she was the UCL Pro-Vice-Provost (Postgraduate Education) and Joint Director of Education at the UCL Institute of Ophthalmology and Moorfields Eye Hospital.
She has been a Professor of International Economics at Drew University, USA; Dean of Business and Deputy Vice Chancellor at University of East London (UEL), UK; and a visiting professor in the School of Public Administration at the University of Electronic Science and Technology (UESTC), Chengdu, China as well as the American University in Beirut (AUB), Lebanon. She holds a doctorate from University of Oxford, UK.
She also has studied and taught at a number of leading universities including Harvard University; W. P. Carey School of Business at Arizona State University; American University in Cairo; American University in Beirut and Barcelona Business School at University Pompeu Fabra, Spain. She also holds a certificate in Change Management from Cornell University in the USA.
She has been the recipient of a serial Fulbright and a Carnegie Foundation grant to conduct fieldwork in the Middle East.
She is the author of numerous journal articles concerned with Middle Eastern economics and politics. She is also co-author of a book with Elsevier Press entitled Middle East Finance: Missed-opportunities or Future Prospects and has a book forthcoming with Palgrave-Macmillan on the political economy of Yemen. She has also been a series editor of a book series on Middle East Economics through Palgrave-Macmillan. More recently, she conducts research and publishes on healthcare management and strategic leadership.
She has a particular interest in change management as it relates to the healthcare sector and has designed programmes and taught on healthcare management postgraduate degree programmes as well as health related executive education and training programmes.
- Executive team
Prof Nora Colton email@example.com School Manager Sadaf Alvi Liaqat firstname.lastname@example.org Marketing and Communications Manager Adam Vidler email@example.com Marketing and Events Coordinator Sophie Elwin firstname.lastname@example.org Marketing and Events Coordinator Adeola Adeshina email@example.com Education Administration Manager Andrea Crammond firstname.lastname@example.org Education Coordinator Dawn Mitchell email@example.com Education Coordinator Leila Blackford firstname.lastname@example.org Learning Technologist Marcus Pedersen email@example.com Business Development Manager Cristina Lai firstname.lastname@example.org HR and Finance Officer Juned Ali email@example.com
- Core academic staff
Honorary Professor of Practice Dr Shafi Ahmed email tbc Lecturer in Operations and Supply Management Dr Rodolfo Catena firstname.lastname@example.org Honorary lecturer in Digital Health Hassan Chaudhury email@example.com Director Prof Nora Colton firstname.lastname@example.org Deputy Director EDI, Director MBA Health and Professor (Teaching) Professor Julie Davies email@example.com Principal Research Fellow, Institute of Clinical Trials & Methodology Hakim-Moulay Dehbi firstname.lastname@example.org
Deputy Director Research, Programme Lead for MSc Digital Health and Entrepreneurship and Associate Professor (Teaching)
Dr Adam Dubis email@example.com Programme Lead for MSc Global Healthcare Management and Associate Professor (Teaching) Dr Jennifer Egbunike firstname.lastname@example.org Lecturer in Health Informatics and Graduate Tutor (Research) Dr Paul Expert email@example.com Honorary Research Fellow Dr Bola Grace firstname.lastname@example.org Deputy Director Education, Programme Lead for MSc Biotech and Pharmaceutical Management and Associate Professor (Teaching) Dr Radi Haloub email@example.com Lecturer in Finance and Accounting and Lead International Partnerships, Asia Dr Jenny Zhenyi Huang firstname.lastname@example.org Lecturer (Teaching) in Medical Education Tabassum Jafri email@example.com Lecturer in Health Economics Radhika Jain firstname.lastname@example.org Chair of Board of Examiners, Deputy Director MBA Health and Associate Professor (Teaching) Preethi John email@example.com Professor of Bioprocess Science and Enterprise and Vice Dean International Professor Eli Kesharz-Moore firstname.lastname@example.org Visiting Lecturer Marc Kitten Email tbc Clinical Associate Professor Professor Michelle Heys email@example.com Statistician, Institute of Clinical Trials & Methodology Matthew Nankivell firstname.lastname@example.org Deputy Director Partnerships and Lecturer in Healthcare Marketing Marzena Nieroda email@example.com Visiting Lecturer Olajumoke Okoya Email tbc Professor of Health Informatics Professor Henry Potts firstname.lastname@example.org Visiting Lecturer Simon Rost Email tbc Vice Dean Education and Faculty tutor FPHS Mike Rowson email@example.com Visiting Lecturer Joel Schamroth Email tbc Honorary lecturer in Digital Health Sam Shah Email tbc Lecturer in Human-Computer Interaction Aneesha Singh firstname.lastname@example.org Professor Professor Paolo Tattichi email@example.com Professor Professor Paul Taylor firstname.lastname@example.org Consultant Opthamologist Peter Thomas email@example.com Lecturer in Health Economics and Chair of Student Staff Consultation Committee Dr Sonila Tomini firstname.lastname@example.org Lecturer in Organisational behaviour and Human Resource Management Dr Paola Zappa email@example.com Lecturer in Finance and Accounting Dr Ruijia Zhan firstname.lastname@example.org
- Honorary Professors
Honorary Professor David Probert Email tbc Visiting Professor Mark Britnell Email tbc Visiting Professor Wendy Purcell Email tbc Visiting Professor Chris Outram Email tbc Visiting Professor Tim Irish Email tbc Visiting Professor Simcha Jong email@example.com Visiting Professor Dr Folabi Ogunlesi MB BS DPhil MRCP (UK) firstname.lastname@example.org
- Ruth Kennedy - Chair, UCL GBSH External Board and Brand Consultant
Ruth Kennedy is a brand consultant advising clients in the luxury goods and services sectors to meet their business development objectives. From 2006 to 2009 she served as head of Quinlan Private UK, a real estate and private equity group managing commercial and residential properties in Europe including luxury hotels. Before that position, Ruth was 16 years with David Linley and Co., the bespoke furniture and design business.
She began her career at S.G. Warburg as an investment banker. Ruth is a non-executive director on the boards of Daylesford Organic, Bamford, Value Retail (the owners of Bicester Village), and until 2019 on the public board of Belmond Hotels. In 2009 Ruth founded the Louis Dundas Centre for Children’s Palliative Care at Great Ormond Street Hospital and UCL Institute of Child Health and is a Patron of the Elton John AIDS Foundation.
- Fiona Adshead - Chair of the Sustainable Healthcare Coalition, UCL Alumni
Fiona chairs the Sustainable Healthcare Coalition that inspires partnerships and action on sustainable healthcare. She also works as an independent expert advisor and board member for national and global organisations on wellbeing and sustainability. Fiona is also a visiting Professor at UCL and teaches at the Cambridge Institute for Sustainability Leadership.
She is a high-profile wellbeing and public health leader with a track record of reframing thinking and developing innovative strategy and programmes at the heart of business and government. Her previous roles include Deputy Chief Medical Officer and Director General in the UK Government, Director of Chronic Disease and Health Promotion at the World Health Organisation and Bupa’s Chief Wellbeing Officer.
- Simon Hammett - Retired Senior Partner at Deloitte (Healthcare and Life Sciences practice in Europe), UCL Alumni
Simon Hammett was a Senior Partner at Deloitte LLP. He led the Healthcare and Life Sciences practice in Europe and was the CEO of the Strategy Consulting business. Simon operated at executive level with the Firm’s most prestigious clients in the consumer health, pharmaceuticals and medical devices sectors.
He provided advice on commercial strategy, organisation design and merger-integration. Under Simon’s leadership, the practice achieved significant growth and he built a talented team of Partners all passionate about making an impact that mattered for clients and their patients.
Simon “retired” from Deloitte in 2016, completed an MSc in Industrial, Organisational and Business Psychology at UCL and now operates as a Board advisor and leadership coach. He is a Trustee with several leading healthcare charities.
- Graham Hart - Co-Director of UCL Health of the Public
Professor Graham Hart was the inaugural Dean of the Faculty of Population Health Science. He is now the Co-Director of UCL Health of the Public.
Graham is a Professor of Sexual Health & HIV Research and his research interests include sexual risk behaviour and the prevention of HIV and STIs, combining structural, behavioural and biomedical approaches to prevention and the opportunities afforded by new prevention technologies. He has worked with a wide range of populations at risk of HIV and STIs, nationally and internationally.
- Jitinder Saini - Senior Vice President and Head of Medical Affairs for EMEA, UCL Alumni
Dr Jit Saini is Senior Vice President and Head of Medical Affairs for EMEA, a role he has held since 2017. Jit initiated, led and ran the Medical 2020 program that started in 2017, which culminated in the transformation of the Medical Affairs function at Merck.
Prior to this role, he acted as the Global Chief of Staff and Head of the Strategy Realisation Office within Merck KGaA Darmstadt Germany, where he was a member of the Healthcare Executive Committee.
Jit studied medicine and achieved his postgraduate qualifications from London teaching hospitals, including The Royal Free, Kings College and University College London. Prior to entering the pharmaceutical industry where he worked with companies such as Roche and Bristol-Myers Squibb, Jit specialized in hepatology and gastroenterology.
- Hari Kumar - Entrepreneurial pharmaceutical executive, UCL Alumni
Hari Kumar is a pharmaceutical executive with over 30 years of experience in the industry.
He started his pharmaceutical career at Roche, before joining Amira Pharmaceuticals before becoming the Chief Executive Officer of Adheron Therapeutics. Since then, Hari has been actively involved in helping Biotech start-ups either as an independent Board member or as consultant. He is currently Chairman of the Board of Kinarus AG, on the Board of TRIO Inc, advisor to Mantra Bio, Inc. and Pliant Therapeutics, Inc.
Having completed his PhD as an immunologist at University College London, Hari completed a postdoctoral fellowship at Tufts New England Medical Center in Boston and another fellowship at the Marie Curie Cancer Research Centre in UK.
- Chris Outram - Founder and former Chairman of OC&C Strategy Consultant and UCL GBSH Visiting Professor
Chris Outram is the Founder and Chairman Emeritus of the OC&C Strategy Consultants partnership and a Visiting Professor at UCL GBSH. After graduating from INSEAD Business School, Chris worked with the Boston Consulting Group and then moved onto a new position as a Marketing and Strategy Director. Chris then joined Booz Allen & Hamilton as a strategy consultant and was elected Partner of the firm in 1986.
In January 1987, Chris co-founded OC&C Strategy Consultants which operates out of multiple offices in 7 countries around the world and boasts over 500 consultants. OC&C is one of the world’s premier specialist strategy consulting firms, with many of the world’s leading companies amongst its client base.
He has also Chaired three other organisations over the last five years – a small but very high growth technology company, the U.K.’s leading eating disorders charity, as well as a relatively new and high growth (~35% p.a.) charity which brings education to ‘un-reached’ children around the world at a very low cost. It now serves more than 20,000 children across three countries.
Chris approached UCL in 2016 with the idea for the concept of a global business school for health that has now been taken forward by UCL.
- Dr. Ali Parsa - CEO and Founder, Babylon Health, UCL Alumni
Dr Ali Parsa is a British-Iranian healthcare entrepreneur and engineer. He’s the founder and CEO of Babylon, the revolutionary artificial intelligence and digital health company. Babylon’s mission is to put an accessible and affordable health service in the hands of every person on earth.
Dr Parsa was listed in The Times 100 people to watch. The Health Service Journal recognised him as one of the ‘50 most influential people in UK healthcare’. He was featured in the Maserati 100, a list that recognises game-changing entrepreneurs who are disrupting the world of business. The Independent Healthcare Awards presented Dr Parsa with an Entrepreneurial Achievement award. He is also a UK Cabinet Office Ambassador for Mutuals and has a PhD in Engineering Physics.
- Bing Song - Vice President of the Berggruen Institute (in charge of the China Centre, PKU) and former senior executive at Goldman Sachs China
Bing Song is a Vice President of the Berggruen Institute and Director of the Institute’s China Centre.
Prior to joining the Berggruen Institute, Ms. Song was a senior executive with Goldman Sachs China for over a decade, with varying roles such as General Counsel and COO of the China business and finally, General Manager of Goldman Sachs’ joint venture securities firm in China.
Prior to Goldman, Ms. Song practised international securities law for many years in Hong Kong. Earlier in her career, Bing undertook academic and policy research and published in the areas of administrative law, competition law and comparative procedural laws.
- Dr David Walcott - Novamed Managing Director and Founder
David is a Medical Doctor (MD., Ph.D., MSc.) and Entrepreneur who is committed to bringing world-class healthcare to the Caribbean & Latin America, He is the Founder of Novamed, a healthcare firm actioning best-practices and global insights through portfolio companies spanning healthcare services, medical education & health innovation.
He is Founding Partner of The Visionaries’ Summit, an opportunity exchange platform convening a community controlling US$140 billion in equity that has seeded over US$300 million in investments in the Caribbean.
He has been recognized by Forbes, World Economic Forum, the United Nations and the IMF and is currently a member of the WEF Global Future Council & Young Global Leader communities. His academic profile includes Oxford, INSEAD, Harvard & the Rhodes Scholarship.
- Soroosh Shambayati, Director, Time Boost Capital
Soroosh Shambayati was born in Tehran, Iran and was educated in Sweden and United States. He received a Bachelor’s degree in Mathematics and Chemistry from Occidental College, Masters of Science and Philosophy degrees from Yale University and a PhD from Harvard University. His PhD work, under the supervision of Professor Stuart Schreiber, covered the total synthesis of Epoxydictymene, design of Targeted Inhibitors for the HLA-B27 and the structural properties of Silyl Ethers.
Dr. Shambayati’s career in finance commenced at Bankers Trust in New York. He then moved to Goldman Sachs as a member of the Fixed Income Arbitrage Group focusing on Emerging Markets. More recently, he was Global Chairman of Emerging Markets at Nomura International and Global co-Head of Sales and Trading at Renaissance Capital in Moscow.
As a shareholder and partner of LJ Partnership (now Alvarium Investments), Dr. Shambayati helped grow the wealth management business by structuring and negotiating various mergers and acquisition deals, most notably with Guggenheim Investment Advisors. He continues to advise a select group of families on their investments.
In 2019 he co-founded AIBEAM Labs, a research firm exploring a combination of behavioural science and machine learning tools in construction of investment portfolios. He currently divides his time between Singapore, Geneva and London.
Health Executives in Residence
Being leaders in their respective fields and industries, our Health Executives in Residence are not only here to help you reimagine healthcare for the future but are also here to ensure you graduate from the Global Business School for Health with experiences that mirror the real work of health. We believe that the interactions you have with our Health Executives in Residence will challenge and shape your aspirations and career paths.
- Michael Allen - Partner & Head of Health & Human Services, KPMG
Michael is the Global Lead for Health and Care Workforce Solutions at KPMG, a role which gives him oversight and understanding of the activities underway in 38 countries to address the global workforce shortage. Michael also leads the Health and Human Services Consulting Team in the UK.
Michael recently led work with the Northern Care Alliance to develop an integrated activity, cost and workforce model. This model allows the Trust to forecast its’ future workforce requirements for over 300 roles with a high degree of accuracy based on service demand, planned changes to its service model and it’s digital strategy.
In March and April 2020, Michael led work on Nightingale London (Excel) and then Nightingale Yorkshire & Humber. During a 13 day period, KPMG mobilised over 200 people to work alongside the NHS, the military and contractors to build the largest ventilated unit in the world in the Excel conference centre. His specific responsibilities during this time included the translation of the clinical model into a workforce model and securing agreement to it with the Heads of the Professions for England. This model was subsequently replicated across England. In parallel. Michael led the team which created the new Clinical Support Worker role with NHS Employers and recruited over 500 civilians to it; and worked alongside Health Education England (HEE) to induct, orientate and train over 3500 people for over 50 different roles.
In 2019/20, Michael led a large, nation-wide programme of work for the NHS in England to develop the System Workforce Improvement Model (SWIM) and deploy it in a number of Integrated Care Systems. The findings from this work have been used to inform the NHS People Plan. He is currently advising the Department of Health & Social Care on workforce reform.
In the last two years, Michael has also helped establish the Centre for Workforce Development in Bradford and the Leeds Health & Care Academy; two separate partnerships between employers and educational providers to develop the pipeline of health staff and help those already working in the sector to operate at the top of their licence.
In 2014, Michael was awarded the Management Consulting Association (MCA) Award for Public Sector Improvement Programme of the Year for his work supporting the reconfiguration of services across Mid-Yorkshire Hospitals.
Prior to completing his MBA, Michael spent 11 years working in the NHS where he held a number of roles including Head of Primary Care for a Primary Care Trust, NHS Local Improvement Finance Trust (LIFT) Director for Leeds and Head of Operations at Leeds Teaching Hospitals. Michael is a visiting lecturer at University College London and a Non-Executive Director of Age UK (Leeds).
- Silvia Cerolini – CEO, Eyes on the Future
Silvia is an experienced leader with 16+ years operational and strategic experience in the Pharma and Consumer Goods industries with focus on innovation, data and analytics.
She currently leads the Health Informatics Rare Disease team at Sanofi UK. Her goal is to leverage Data and Artificial Intelligence to accelerate diagnostics of patients with rare diseases and significantly reduce the diagnostic odyssey.
Silvia is also a successful social entrepreneur. Since her daughter was diagnosed with an ultra rare eye disease leading to blindness, Silvia has been actively advocating for advancing treatments for inherited retinal dystrophies. She funded Eyes on the Future, a UK based charity, aiming to accelerate research for her daughter's disease. She leads the global patient organization catalyzing collaboration between academia, industry and patients. Her work led to several publications and, most importantly, concrete progress towards potential treatments. Her efforts have been featured in national and international press including BBC, Vanity Fair, London Evening Standard.
Silvia is extremely passionate about the role of innovation and data in transforming health care especially for patients with rare diseases. She is very excited about engaging with the next generation leaders at UCL Global Business School about the impact that business skills can make in health care and life science.
- Jim Dawton - Director, Impeller Ventures
Jim Dawton has worked in many of London’s foremost design consultancies, most notably as Associate Director at Seymour Powell, Managing Director at Pearson Matthews and a Founding Partner of Designit London. During this time, he has designed consumer products for international brands; medical devices for the healthcare industries and behavioural change solutions for the healthcare system. With health being a specialist area, Jim has the ear of many of the UK’s key players in the sector; from policy makers and innovation directors through to entrepreneurial investors and business leaders. It is Jim’s unusual approach and vision that has attracted attention during is career which spans more than 30 years.
Jim is currently a Director at Impeller Ventures, a business he co-founded in order to pioneer a new approach to innovation. He was previously a Director at the US software services firm EPAM Systems, and prior to that held a consulting role with the UK Government’s Technology Strategy Board (now Innovate UK) as their Lead Design Specialist. He has been an advisor to the Associate Parliamentary Design and Innovation Group and a member of the Associate Parliamentary Health Group. He formerly held advisory roles on the UK Government’s National Measurement System’s “Quantum, Electromagnetics & Time”, “Innovation Research & Development” and “Digital” Programme Expert Groups. He currently sits on their “Life Sciences & Health” Programme Expert Group as well as being a Mentor on the NHS’s Clinical Entrepreneur Programme.
Jim is frequently asked to lead teams on international design challenges, and often judges design competitions. He regularly gives talks and lectures to a wide range of international design, healthcare, business and academic audiences. Jim studied Industrial Design at Newcastle-Upon-Tyne Polytechnic, is a Fellow of the Royal Society for the encouragement of Arts, Manufactures and Commerce and a Visiting Fellow at Cranfield University’s School of Management where he lectures on innovation to the Executive MBA.
- Deirdre Dinneen - Senior Partnerships Manager at Kheiron Medical Technologies
Dee is Head of UK Partnerships at London-based start-up Kheiron Medical Technologies. Kheiron combine novel deep learning methods and radiology insights to find malignancies in mammograms and were the first UK company to receive a CE Mark in deep learning and radiology. Dee’s work focuses on creating meaningful collaborations with NHS partners in order to deliver multidisciplinary data-driven projects that facilitate the development, evaluation and implementation of Kheiron's deep learning tools. Dee has also worked closely with UK national health authorities to define the standards and processes for safe and effective validation of AI solutions in the UK NHS. Dee has an undergraduate MSci in Genetics from University College London (UCL). She was awarded a postgraduate MSc scholarship in the UCL department of Science and Technology Studies where she became interested in digital health technologies. Prior to joining Kheiron, she ran an NHS- and EU-funded Accelerator programme working with over 60 start-ups to understand and navigate the NHS. Dee is a Fellow of the global network OneHealthTech, a volunteer-led community which champions diversity in health innovation. Outside of health tech, Dee enjoys playing touch rugby, spending time with friends and family, and wild swimming.
- Dr. Brian Donley - CEO, Cleveland Clinic London
Dr. Brian Donley is Chief Executive Officer of Cleveland Clinic London. Prior to this appointment, he was Chief of Staff (Medical Director) and Chief of the Clinical Enterprise for the Cleveland Clinic Health System beginning January 2015. Previously, he served as President of Regional Operations for the Cleveland Clinic Health System.
Dr. Donley is Professor of Surgery at the Cleveland Clinic Lerner College of Medicine and Fellow of the Royal College of Surgeons. He attended the University of Notre Dame, graduating Phi Beta Kappa, the oldest academic honour society in the U.S.
He graduated with Distinction from the University of Michigan Medical School and completed his residency in orthopaedic surgery at the University of Michigan. He also attended Harvard Business School completing the Advanced Management Program.
- Peter Ellingworth - CEO Association of British HealthTech Industries
Peter leads the Association of British HealthTech Industries (ABHI), the UK’s leading HealthTech trade association, representing 330 companies in MedTech, diagnostics and digital health. ABHI advocates industry’s needs at senior government level, supports UK market access, informs on commercial matters, provides regulatory advice, promotes ethical compliance and develops international trade opportunities for SMEs.
Representing industry across government, Peter currently sits on the Secretary of State led Life Sciences Council, and the sector specific Health Technology Partnership which supports it. Peter also serves on the Trade Secretary's Life Sciences Trade Advisory Group, the Ministerial led Life Sciences Global Opportunities Board, the Life Sciences Scotland Industry Leadership Group and the advisory panel of Healthcare UK.
A Board member of the Oxford AHSN, Peter leads work to enhance collaboration between ABHI members and the AHSN national network, most recently through the newly constituted MedTech Innovation National Network.
Peter chaired the Health Economy work stream of the London Health Commission that was established by the Mayor of London and Lord Ara Darzi. He is a former Board member of MedTech Europe, and the immediate past Chair of their National Association Network. He has also Chaired the Greater Manchester AHSN and previously sat on the advisory Board of Healthcare UK.
Peter has 35 years’ experience in sales, marketing and general management in the UK and across Europe and as a non-executive director of early stage companies. He is a proud member of the 30% Club, which campaigns for greater representation of women at senior leadership and board level, with a target of a minimum of 30%.
Peter is also a GlobalScot - a worldwide network of business contacts who are experts in their field, and driven to help Scottish companies develop, expand and thrive in a competitive international market.
- Mark Fountain - CEO, Healthcare Business Solutions
Mark Fountain is an accomplished Healthcare professional, having acted as Hospital Director, COO and CEO for various Healthcare businesses across the world and having run numerous hospitals. Mark founded Healthcare Business Solutions (UK) Limited (HBSUK) in 2012 and the company has just celebrated its 10-year anniversary. As founder and CEO, Mark has led this business from humble beginnings to be a leading business in providing physical (clinics and surgical procedures) and digital solutions, via the company’s own Virtual LucyTM assessment and treatment platform. Services are provided to the NHS and private providers, including the UK’s largest private medical provider, AXA, whereby HBSUK provides services for MSK and Dermatology. HBSUK now employs more than 50 full-time people plus over 1000 part-time healthcare professionals (consultants, nurses, AHP’s) and runs an almost entirely virtual business with a net positive carbon footprint. Mark’s understanding of the UK healthcare market is second to none.
- Chris Gibbons - Director of Digital Health & Technology Transformation at KPMG
Chris is a Director at KPMG leading the UK Digital Health Practice. He is passionate about the opportunities presented by digital to improve access, experience and outcomes for patients and the health and care workforce.
Chris has worked at national level and with healthcare providers for over a decade. He sits on the Board of a VCSE Mental Health Provider delivering IAPT services across England and specialist services in the North East. Chris has led on digital strategy, road-mapping and large-scale delivery engagement for several national services including ERP, digital workplace, cyber security, and infrastructure services. His experience at local level has focused on Clinical Systems Transformation and Digital Strategy development.
Chris studied at Durham University and lives in Cumbria; where he can often be found ticking off the Wainwrights or Paddleboarding in the Lake District.
- Toby Goldblatt - Co-Founder, Pivot Digital Health
Toby is the Co-Founder of Health Tech scale-up Pivot Digital Health. His 25-year career has included periods as EVP/SVP in Tech corporates (Accenture/Avanade; Atos; CACI) and as a founder of startups and advocate and ally for rare talent from across the world, both through his own initiative and via supporting progressive organisations (Teens in AI; Microsoft Education; Junior Achievement; Princes Trust).
In recent years, he has led and worked on some ground breaking Health Tech programs (WHO / Covid; Norwegian Health Data Platform; Digitisation of NHS Trusts; AI for Genomics England & NHS Blood & Transplant; Covid Virtual Agents for Governments of Catalunya and India; Digital Therapeutics). He has also extensive experience supporting leading Biopharma (Novartis; Roche; Sanofi; GSK etc) to enhance their capabilities. Today, his organisation Pivot Digital Health helps Biopharma reach global audiences via advanced tech and communications, operating in a radically different virtual first way; and giving rare young talent from across the world the opportunity to impact major healthcare organisations early in their careers.
He lives in London with his wife and 3 girls and enjoys travel, political cartoons, rugby, American football, cooking and running.
- Dr. Joanne M. Hackett - Head of Genomic and Precision Medicine at IQVIA
Joanne is the Head of Genomic and Precision Medicine at IQVIA and previously was the Chief Commercial Officer at Genomics England.
Dr. Hackett is a clinical academic, entrepreneur, investor, and a strategic, creative visionair with global experience spanning successful start-ups to Fortune 500 companies. Aside from her curious passion for life and positivity, Joanne is known for building innovation, driving personalised medicine and leading through fast paced, complex changing ecosystems and integrations. Joanne's goal is to contribute to bringing the world novel, cost effective and simple health care solutions, and she is particularly keen on building the case for prevention, open science and citizen genomics. She has extensive global experience across academic, business and clinical institutions, and enjoys sharing her experiences with the Boards she sits on as well as companies she provides strategic advice to.
Joanne has been publicly recognised for her relentless pursuit of revolutionising healthcare and has been named one of the top six Influential Leaders in Healthcare by CIO Look, the Accenture Life Science Leader of the year, Freshfields Top 100 Most Influential Women, One HealthTech Top 70 Women in the NHS, Pharmaceutical Market Europe’s 30 women leaders in UK healthcare and BioBeat Top 50 Women in Biotech Award. Joanne believes in human courage and perseverance against the odds, and demonstrates that positive change, whether in a company or in one’s personal life, can be carved out from even the greatest of trials. As a believer of ‘health = wealth’, Joanne is an internationally known yoga instructor.
- David Hare, Chief Executive, Independent Healthcare Providers Network (IHPN)
David Hare is the Chief Executive of IHPN, which represents over 100 independent healthcare providers across the United Kingdom - bringing them together, supporting them to deliver great care to both NHS and private patients, and enabling them to make a positive contribution to UK healthcare. In his role as CEO, David leads the team and helps to steer the network’s work programme on behalf of our members, and well as acting as the principal public voice of the organisation.
Previously, David was a Director at The Whitehouse Consultancy, a political communications firm based in London. At Whitehouse, David built and led the company’s public services team, providing advice and support to a wide range of organisations involved in delivering health, education, children’s services, social care and welfare-to-work programmes.
David has also acted as the Director of Strategy for the LIFT Council, the trade body that represents the private sector equity investors in the Local Improvement Finance Trust programme, overseeing all of their engagement with Government bodies.
- Dr Linda Harris - CEO, Spectrum
Dr. Linda Harris OBE FRCGP is the founding Chief Executive and Chief Medical Officer of Spectrum Community Health CIC, a not-for-profit organisation delivering a range of community and health and Justice services on behalf of the NHS, Local Authority and other partners in sites across the North of England. She is also the current chair of the Clinical Reference Group for Health and Justice for NHS England.
Linda is a former Wakefield GP and passionate advocate for patient centred, values-based services with an interest in inclusion health, system change, substance misuse recovery and workforce wellbeing.
Linda is also a Trustee of the Charity Spectrum People and Executive Chair of SLD Training, a subsidiary of the CIC which hosts the national RCGP accredited Certificates in Substance Misuse and Associated Health training programmes.
Linda was awarded the OBE in the 2021 New Year’s Honours for services to the NHS.
- Justin Hely, General Manager at GensisCare
Justin has worked exclusively in healthcare for over twenty years. He has extensive experience leading the development and execution of organisational and enterprise-wide strategy, organisational redesign and commercial development in public and private companies.
Responsible for leading the UK business of a major international cancer company, he has held several Director-level roles in the acute and diagnostics providers. Married with two young sons, Justin lives in Winchester in the UK.
- Dr. Dimitrios Kalogeropoulos - Senior Independent Adviser, Global Health Innovation,
Doctor Dimitris Kalogeropoulos is independent senior advisor with the World Bank, the WHO, UNICEF and the European Commission, recognised by his peers as thought leader and key policy expert in global health innovation and digital development acceleration. With a PhD in health systems science, he has twenty years of field experience in international development and thirty years in health innovation, clinical evaluation, medical AI, ethics, and innovation ecosystems, working together with governments, high-level strategy and policy committees, think-tanks, multilateral organisations and philanthropic organizations. Dimitris is the former CEO of a management consulting firm and sits on the board of advisors of a number of US companies. He volunteers as a senior member and advisor in the IEEE SA Transforming the Telehealth Paradigm Programme, as mentor in the IEEE EMBS Young Professionals Entrepreneurship Programme for Healthcare Innovation, and as judge and mentor in the Edison™ Accelerator by GE Healthcare and the Wayra global open innovation hub.
- Sean Lybrand - Executive Director, International Health Systems Policy, Amgen Inc
Mr Lybrand is Executive Director, International Health Systems Policy with Amgen, and is based in Amgen’s European hub in Switzerland. He is a highly experienced market access and health policy leader. He has over 20 years’ experience in health, having started his research and health outcomes-focused career in academia in Australia, preparing evidence-based reviews for the Cochrane Collaboration and undertaking health outcomes research in rheumatology.
He has worked across many different regions, therapeutic areas and health care contexts, and has established a range of important partnerships in health, including with academic centres, digital health agencies, and national governments. A key personal highlight of his partnership work was the development and initiation of the first public-private partnership for HPV vaccination in the developing world- initiating a national HPV vaccination program in Bhutan which is ongoing and has recently passed its 12th anniversary.
Sean was previously a Board member of the Australian Cervical Cancer Foundation. Aside from his Amgen role, he has an appointment as Adjunct Fellow at the Centre for the Health Economy at Macquarie University in Sydney, Australia. He holds a BA, BSc and MPH from the University of Queensland (AU) and a Graduate Certificate in Health Economics from Curtin University (AU).
- Justin Mason-Home, Owner/Director, HPAPI Project Services Limited
Justin Mason-Home is an organic chemist with extensive health, safety, environmental and chemical engineering experience in senior technical, legal and commercial aspects of the pharmaceutical, biochemical, chemical and other industries. He is a Fellow of the Royal Society of Chemistry in the United Kingdom.
Justin started as a research chemist in the flavour and fragrance sector, researching and discovering new chemical synthetic routes to produce nature-identical flavour and fragrance components. In the fine chemical sector, he worked through R&D, scale-up (Kilo Lab then Pilot Plant) to full-scale manufacture. After a move to corporate environmental management, Justin was head-hunted into environmental consulting, heading a technical environmental engineering function.
He has since held senior positions and worked globally in potent biopharmaceutical occupational health and safety and a board level position in a biotechnology company. Mr Mason-Home has been involved in and worked on potent and highly potent API projects over more than 25 years and specialises in technical complex and strategic projects, including unique experience in managing sensitive highly potent and toxic biopharmaceutical compound matters. Justin has chaired, presented at and attended many ‘HPAPI’ events and is a recognised expert in this area.
- Don McDaniel, CEO Canton & Company
Don McDaniel engages with pioneering healthcare firms across the industry, all striving to win in the new health economy. A true market-maker, he focuses on advancing innovation, elevating market positions, and connecting complementary players to disrupt and reshape the industry.
An industry leader and serial entrepreneur with more than 25 years’ experience, Don has experienced healthcare’s dysfunction from many seats. He has launched several healthcare businesses, is a former hospital, health services, technology, and insurance industry executive, and an operating partner for a venture capital firm focused on turning around distressed health plans. Consistent across his diverse background is helping disruptive healthcare companies of all sizes and at various stages succeed.
Don is a seasoned board member, executive advisor, and investor. He is a recognized thought leader and health economist, and a dynamic, entertaining, sought-after speaker, writer, and facilitator. He has delivered hundreds of speeches across the industry, including offering keynote addresses for some of the most relevant industry groups.
Prior to founding Canton & Company, Don was the Founder, Chairman and CEO of Sage Growth Partners, Vice Chairman and CEO of Continuum Health, SVP and General Manager, Consulting of Northrop Grumman Health IT; he was an Operating Partner of Venture Health Partnership Group, and Vice President, Business Strategy with the Bon Secours Health System. He started his career as the founder of a physician practice management company and a partner in a healthcare strategy and information technology consulting firm.
A long-time advocate for education, Don was named the first Entrepreneur-in-Residence for the Jefferson University College of Population Health, and just recently as the inaugural Health Executive in Residence at the new UCL Global School for Health. He taught health economics and graduate business courses at numerous universities, including an almost 20-year engagement at Carey Business School and the Bloomberg School of Public Health, both part of The Johns Hopkins University.
He loves helping entrepreneurs and leaders innovate with their companies, is an unabashed Clayton Christensen and Milton Friedman devotee, a convicted believer in the power of markets, and committed to disrupting the old order to reshape the healthcare industry.
- Johanna Moss - Director of Strategy at Moorfields Eye Hospital NHS Foundation Trust
Jo is an experienced health leader with 20 years of operational and strategic experience within the NHS who is passionate about improving population health in partnership with residents and staff. She has extensive experience of leading strategy development, large scale clinical transformation programmes and complex new hospital projects working at Provider, Regional and National level.
Jo is currently the director of strategy and partnerships at Moorfields Eye Hospital NHS Foundation Trust where she is accountable for marketing and communications, external relations, strategy development and Oriel – a complex £0.5bn new build and transformation partnership project with UCL and Moorfields Eye Charity.
Jo is a military veteran and completed a six-month tour of active service in Afghanistan.
- Rachel Murphy - Public speaker, health tech advisor, investor
Rachel is a Public speaker, health tech advisor, investor and currently writing a book about the concept to sale of a digital business (Difrent).
Since leaving the NHS, Rachel has brought her passion for good services for all, bringing user needs, service design, and actual delivery together for clients. In just 1,000 days, Rachel built and sold Difrent, which is an award winning delivery business providing services into Government and Health services.
Since leaving Difrent, Rachel has taken 4 months off to finish writing the book, she continues as NED of Careology and has recently returned from helping on the front line in Ukraine having raised 20k to support refugees.
- Ben Osborn - Regional President Hospital, International Developed Markets, Pfizer
After graduating from Leeds University Ben joined Pfizer in 1998, where his career has taken him through a variety of leadership roles both in the UK and internationally.
In recent years Ben served as Chief Marketing Officer across Europe, Japan, Korea and ANZ where he led the digital transformation of the commercial organisation and innovative partnerships across the sector. He is passionate about organisational culture and purpose to ensure patients benefit from breakthrough innovation and science. Most recently he was the UK Country Manager and Managing Director for Pfizer UK, leading the organisation through unprecedented times of opportunity to bring science, data and technology together to transform healthcare. He led the UK roll out of Pfizer’s Covid19 vaccine and antiviral, working closely with government and the NHS.
In January 2022, Ben was appointed Regional President, Hospital Business for the International Developed Markets region (57 countries across the globe), where he is responsible for Pfizer’s Infectious disease medicines and specialist hospital medicines.
Ben served as President of the Association of the British Pharmaceutical Industry from May 2021 to April 2022 leading the industry through a critical period for the sector and represented UK industry on a number of committees with government and NHS. He is also an advisory board member for the EU HBA organisation.
- Lloyd Price, CEO and Founder, Hive Health
Lloyd is a technology entrepreneur, corporate executive, board advisor & non-executive director with 25 years of experience building digital businesses in 8 industries - healthcare, cyber security, retail, travel, finance, automotive, advertising and dating.
Lloyd has performed senior management, C-Level & founder roles @ Hive Health, Induction Healthcare, Zesty, Badoo, Kelkoo, Yahoo! UK and Yahoo! Europe. His operational experience ranges from start-ups to scale-ups, corporates to Nasdaq and FTSE listed companies.
Lloyd co-founded Zesty in June 2012, building the company through multiple investment rounds from leading European & US Venture Capital funds into an award-winning UK Digital Health company and sale to Induction Healthcare Group PLC in May 2020 (FTSE AIM: INHC).
Lloyd is Chief Executive Officer & Founder of Hive Health, leading a diverse team of cyber security, data science, machine learning, clinical, operational & commercial executives with multiple exits in Healthcare and Technology. Hive Health is a cyber security company focused on healthcare.
Lloyd graduated from Coventry University with a BA Hons Business Administration and also attended London Business School completing the Corporate Finance programme specialising in Private Equity and Venture Capital.
- Dr. Karen Prins - COO, Circle Health Group
Karen is the Chief Operating Officer for Circle Health Group. Prior to this appointment, she held the position of Chief Executive Officer of BMI Healthcare in the UK, as well as a number of senior roles within Netcare in South Africa.
She has extensive experience in managing multisite hospital operations, the implementation of large-scale capital investment projects and turnaround interventions. She was instrumental in commissioning and operationalising the largest Public Private Partnership in Africa, through partnerships with the Ministries of Health and Finance, the World Bank and the Development Bank of Southern Africa.
Karen started her career as a practising GP and holds a MBChB, a Master Degree in General Practice (MPax Med) (Cum Laude), a MBA (Cum Laude) as well as a project management qualification, all from the University of Pretoria, South Africa.
- Dr. Anthony Renshaw - Regional Medical Director, EMEA Practice, International SOS
Dr. Anthony Renshaw is a chief medical officer to numerous global organisations, advising on public health, emergency response and corporate health. Since joining International SOS in 2008, he has worked widely across Europe, Africa and Asia-Pacific, and has overseen healthcare delivery platforms in both remote and urban health settings across the world including China, Mongolia, Russia, Korea, Japan, Australia and Papua New Guinea. Through this, he has developed a keen interest in the complex interplay between global health and the private sector.
Prior to joining International SOS, Anthony was a surgeon in the UK and South Africa. He is a Member of the Royal College of Surgeons of Edinburgh, where he is an Associate of the Faculty of Rural, Remote and Humanitarian Healthcare; a Founding Fellow of the Faculty of Medical Leadership and Management; and a Fellow of the Royal Society for Public Health. He holds a doctorate in surgery from UCL, and an Executive MBA from INSEAD. He read medicine at the University of Manchester, where he also holds degrees in immunology and oncology.
- Rubén Rojas - CEO Fractal EDM
Rubén Rojas is the Chief Executive Officer of Fractal EDM, a company dedicated to the economic analysis of health care. His professional background is extensive, starting from corporate finance and strategy in his early career, moving later to clinical epidemiology, biostatistics, and health economics in the last ten years.
In his role as CEO since 2016, he has led Fractal EDM to stay in the research frontier of health economics and apply a solid perspective of corporate and finance strategy, using all the available tools to strengthen the company's competitive advantage. The focus on innovation for their products and services is the reason for continuous growth and expansion to new markets since their start.
Alongside his executive role in Fractal EDM, he was an advisor to the Chilean Ministry of Health (2018-2019) and a former member of the health reform committee appointed by the President of Chile (2018).
His professional background started in 1996 with a BSc in Business Administration. After 15 years working in corporate finances, he decided to move to a more socially oriented career, choosing health as his next challenge. In 2017, he got an MSc in Economic Evaluation for Health Technology Assessment from The University of York. After his MSc, he got other certifications such as Measurement, Design and Analysis of Health Outcomes Research from Harvard T.H. Chan School of Public Health; Value-Based Health Care from Harvard Business School; Behavioural Economics from Harvard Business School and Corporate Strategy from Wharton Business School.
Rubén is currently a Lecturer in Health Economics for postgraduate students in the Faculty of Chemistry of Pontificia Universidad Católica de Chile regarding the academic roles. In 2018, he was a Lecturer of Economic Modelling for Health Technology Assessment in the Faculty of Medicine of the same University. He also has been visiting professor in Universidad de La Frontera (Chile), Universidad de Antofagasta (Chile) and Universidad de Panamá (Panamá).
- Dr. Anthony (Tony) Sedgwick - Life Science Strategist/Scientific Advisor
Dr. Anthony (Tony) Sedgwick is an experienced biotech executive, bringing over 40 years of international experience in the sector to Emergex. He was head of anti-inflammatory Biology at Roche between 1986-1990, and after a 2 year period in Marketing at Roche became Global Head of Clinical operations until 2002.
At Roche, Tony was responsible for clinical development, leading to the launch of several products including Invirase® and Tamiflu® which have had significant impact both medically and commercially.
During his career, Tony has been the Chief Executive Officer of four biotechnology companies, Cambridge Biotechnology (2002-2005), DanioLabs (2005-2007), Novacta (2007-2011) and Silence Therapeutics (2011-2012), two of which successfully exited. He has also held Chairman positions at several companies including Plastid AS (2008-2011), ThioLogics (2011-2013) and most recently at Cotton Mouton Diagnostics (2017-2019).
During the past few years, Tony has specialised in ‘trusted’ advisor roles for CEOs and heads of R&D.Tony holds a PhD in Experimental Pathology from St Bartholomew’s Hospital Medical School in London and is a Fellow of the Royal College of Pathologists and an honorary Professor at Swansea University Medical School.
- Sara Siegel - Lead Partner for Healthcare, Deloitte UK and North and South Europe
Sara leads Deloitte’s Health Practice in the UK and across North and South Europe. This encapsulates the firm’s work with the NHS in the UK and with public sector healthcare clients across Europe. Sara’s passion for health began when she first moved to the UK in 2003 and was first exposed to the NHS.
Sara believes passionately in the mission of the NHS and sees the incredible value that a health service free at the point of need provides to society. With her teams, she supports the NHS to do more and better with the resources at its disposal. Some of Sara’s work includes supporting the government on its Coronavirus testing programme, and the introduction of robotic and cognitive automation to improve the speed and quality of NHS services and to release more time for direct patient care. It is the introduction and uptake of new innovative practices either pioneered by individuals or tested first in other health systems around the world that Sara most enjoys working with her NHS clients on.
Sara is also a trustee of the Peter Sowerby Foundation which supports healthcare causes. She is an independent advisor to Med24, a private medical clinic and she is a trustee of the Conservation Collective, an environmental charity that promotes local teams working to solve environmental problems.
- Professor Brian D Smith - Founder Pragmedic
Professor Brian D Smith is a world-recognised authority on the evolution of the life sciences industry. After gaining his undergraduate degree in chemistry from Newcastle University, he worked in the industry for 20 years in R&D, marketing and strategy roles before moving into academia. His PhD, at Cranfield University, uncovered why some firms make strong strategies and others don’t. He now works at Bocconi University and the University of Hertfordshire, where he supervises a research group of PhD students who apply Darwinian thinking to the evolution of the pharmaceutical and medical technology sectors.
He has published over 300 books, papers and articles in this area, including “The Future of Pharma”, “Darwin’s Medicine”, “Brand Therapy” and, most recently “Leadership in the Life Sciences”. In addition to his research and writing, Professor Smith advises many of the industry’s leading firms about the evolution of their business models and the adaptation of their competitive strategies to their changing social and technological environment. He welcomes comments and questions on his work.
- Adrian Stevensen - CEO Independent Care
A career health business executive, Adrian has a huge depth of knowledge and experience in the design, commissioning, funding, operation management and governance of complex multidisciplinary projects. With over 32 years of experience driving private healthcare innovation in the UK and advising in international markets, he brings insight, prescience and the ability to proactively manage multifaceted stakeholder relationships.
Adrian is founder and CEO of Independent Care, delivering state of the art medical facilities across the UK. He is one of the most experienced developers and operational directors of private hospitals, mixed use diagnostic facilities and primary care centres in the UK.
He co-founded one of the leading private GP companies in the City of London and has also built a successful consultancy company advising the NHS and supporting investors and operators in international healthcare markets. As a Board member of IHPN, the Independent Healthcare Providers Network, he was a key influencer working with Central Government, the NHS, and other key stakeholders including the GMC and BMA in all aspects of governance and policy with implications for the sector.